Barry A. Pepers

826 total citations
27 papers, 677 citations indexed

About

Barry A. Pepers is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Barry A. Pepers has authored 27 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 7 papers in Neurology. Recurrent topics in Barry A. Pepers's work include Genetic Neurodegenerative Diseases (16 papers), Mitochondrial Function and Pathology (11 papers) and Muscle Physiology and Disorders (6 papers). Barry A. Pepers is often cited by papers focused on Genetic Neurodegenerative Diseases (16 papers), Mitochondrial Function and Pathology (11 papers) and Muscle Physiology and Disorders (6 papers). Barry A. Pepers collaborates with scholars based in Netherlands, China and New Zealand. Barry A. Pepers's co-authors include Gert‐Jan B. van Ommen, Willeke van Roon‐Mom, Wiljan Hendriks, Bé Wieringa, Edwin Cuppen, Johan T. den Dunnen, Josephine C. Dorsman, Raymund A.C. Roos, Melvin M. Evers and Shuyan Cong and has published in prestigious journals such as PLoS ONE, FEBS Letters and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Barry A. Pepers

27 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry A. Pepers Netherlands 12 538 293 71 70 58 27 677
Dong-Hui Chen United States 9 370 0.7× 277 0.9× 39 0.5× 127 1.8× 83 1.4× 10 579
Lauren Brady Canada 17 360 0.7× 102 0.3× 57 0.8× 72 1.0× 120 2.1× 40 558
Sonia Ciarmatori Germany 11 629 1.2× 312 1.1× 108 1.5× 94 1.3× 88 1.5× 11 1.0k
Maria Piane Italy 14 497 0.9× 165 0.6× 37 0.5× 90 1.3× 90 1.6× 48 719
Chiara Aiello Italy 16 397 0.7× 110 0.4× 64 0.9× 24 0.3× 41 0.7× 34 583
Alessandro Malandrini Italy 16 448 0.8× 246 0.8× 94 1.3× 134 1.9× 67 1.2× 48 734
Laura Davis Keppen United States 14 400 0.7× 419 1.4× 89 1.3× 118 1.7× 157 2.7× 23 887
J. Andoni Urtizberea France 12 398 0.7× 125 0.4× 165 2.3× 34 0.5× 154 2.7× 23 613
Xinghua Luan China 12 242 0.4× 135 0.5× 64 0.9× 125 1.8× 33 0.6× 48 456
Catherine Fressinaud France 15 245 0.5× 233 0.8× 95 1.3× 61 0.9× 43 0.7× 42 655

Countries citing papers authored by Barry A. Pepers

Since Specialization
Citations

This map shows the geographic impact of Barry A. Pepers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry A. Pepers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry A. Pepers more than expected).

Fields of papers citing papers by Barry A. Pepers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry A. Pepers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry A. Pepers. The network helps show where Barry A. Pepers may publish in the future.

Co-authorship network of co-authors of Barry A. Pepers

This figure shows the co-authorship network connecting the top 25 collaborators of Barry A. Pepers. A scholar is included among the top collaborators of Barry A. Pepers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry A. Pepers. Barry A. Pepers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buijsen, Ronald A.M., Linda M. van der Graaf, Barry A. Pepers, et al.. (2024). Calcium-Enhanced Medium-Based Delivery of Splice Modulating Antisense Oligonucleotides in 2D and 3D hiPSC-Derived Neuronal Models. Biomedicines. 12(9). 1933–1933. 1 indexed citations
2.
Buijsen, Ronald A.M., Eleni Mina, Sarah L. Gardiner, et al.. (2023). Spinocerebellar Ataxia Type 1 Characteristics in Patient‐Derived Fibroblast and iPSC‐Derived Neuronal Cultures. Movement Disorders. 38(8). 1428–1442. 8 indexed citations
3.
Pepers, Barry A., Linda M. van der Graaf, Gisela M. Terwindt, et al.. (2023). Amyloid beta accumulations and enhanced neuronal differentiation in cerebral organoids of Dutch-type cerebral amyloid angiopathy patients. Frontiers in Aging Neuroscience. 14. 1048584–1048584. 4 indexed citations
4.
Buijsen, Ronald A.M., et al.. (2021). Antisense Oligonucleotide-Induced Amyloid Precursor Protein Splicing Modulation as a Therapeutic Approach for Dutch-Type Cerebral Amyloid Angiopathy. Nucleic Acid Therapeutics. 31(5). 351–363. 9 indexed citations
5.
Graaf, Linda M. van der, Sarah L. Gardiner, Merel W. Boogaard, et al.. (2019). Generation of 5 induced pluripotent stem cell lines, LUMCi007-A and B and LUMCi008-A, B and C, from 2 patients with Huntington disease. Stem Cell Research. 39. 101498–101498. 3 indexed citations
6.
7.
Buijsen, Ronald A.M., Simone van de Pas, Harald Mikkers, et al.. (2018). Generation of 3 human induced pluripotent stem cell lines LUMCi005-A, B and C from a Hereditary Cerebral Hemorrhage with Amyloidosis-Dutch type patient. Stem Cell Research. 34. 101359–101359. 6 indexed citations
8.
Patassini, Stefano, Eric Kim, Henry J. Waldvogel, et al.. (2017). Effect of post-mortem delay on N-terminal huntingtin protein fragments in human control and Huntington disease brain lysates. PLoS ONE. 12(6). e0178556–e0178556. 2 indexed citations
9.
Pepers, Barry A., Rinse Klooster, Silvère M. van der Maarel, et al.. (2014). Selection and characterization of llama single domain antibodies against N-terminal huntingtin. Neurological Sciences. 36(3). 429–434. 12 indexed citations
10.
Bömer, Nils, Wouter den Hollander, Y.F. Ramos, et al.. (2014). Underlying molecular mechanisms of DIO2 susceptibility in symptomatic osteoarthritis. Annals of the Rheumatic Diseases. 74(8). 1571–1579. 74 indexed citations
11.
Evers, Melvin M., Ioannis Zalachoras, Barry A. Pepers, et al.. (2013). Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon. Neurobiology of Disease. 58. 49–56. 60 indexed citations
12.
Cong, Shuyan, et al.. (2012). Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway. Neurobiology of Disease. 46(3). 673–681. 4 indexed citations
13.
Evers, Melvin M., Barry A. Pepers, J.C.T. van Deutekom, et al.. (2011). Targeting Several CAG Expansion Diseases by a Single Antisense Oligonucleotide. PLoS ONE. 6(9). e24308–e24308. 78 indexed citations
14.
Pepers, Barry A., et al.. (2009). Cost-effective HRMA pre-sequence typing of clone libraries; application to phage display selection. BMC Biotechnology. 9(1). 50–50. 5 indexed citations
15.
Cong, Shuyan, Barry A. Pepers, Raymund A.C. Roos, Gert‐Jan B. van Ommen, & Josephine C. Dorsman. (2005). Epitope Mapping of Monoclonal Antibody 4C8 Recognizing the Protein Huntingtin. Hybridoma. 24(5). 231–235. 15 indexed citations
16.
Cong, Shuyan, Barry A. Pepers, Raymund A.C. Roos, Gert‐Jan B. van Ommen, & Josephine C. Dorsman. (2005). Small N-terminal mutant huntingtin fragments, but not wild type, are mainly present in monomeric form: Implications for pathogenesis. Experimental Neurology. 199(2). 257–264. 6 indexed citations
17.
Cong, Shuyan, Barry A. Pepers, Bernd O. Evert, et al.. (2005). Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Molecular and Cellular Neuroscience. 30(1). 12–23. 91 indexed citations
18.
Schepens, Jan, Arn van den Maagdenberg, Mietske Wijers, et al.. (2002). Colocalisation of the protein tyrosine phosphatases PTP-SL and PTPBR7 with β4-adaptin in neuronal cells. Histochemistry and Cell Biology. 119(1). 1–13. 13 indexed citations
19.
Cuppen, Edwin, Marco van Ham, Barry A. Pepers, Bé Wieringa, & Wiljan Hendriks. (1999). Identification and molecular characterization of BP75, a novel bromodomain‐containing protein. FEBS Letters. 459(3). 291–298. 33 indexed citations
20.
Maagdenberg, Arn M. J. M. van den, Jan Schepens, Marga Schepens, et al.. (1998). Assignment of <i>Ptprn2</i>, the gene encoding receptor-type protein tyrosine phosphatase IA-2β, a major autoantigen in insulin-dependent diabetes mellitus, to mouse chromosome region 12F. Cytogenetic and Genome Research. 82(3-4). 153–155. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026